Medeon Entering Asset Purchase Agreement with Terumo for its Large Bore Vascular Closure System

TAIPEI, , March 5, 2018 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), aTaiwan publicly traded medical device company, is pleased to announce today that it entered into a definitive asset purchase agreement withTokyo -based Terumo Corporation (TSE: 4543) for its large bore vascular closure ...